Organization: Health Canada
Year: 2024
Month: October
Request Number: A-2023-001609
Request Summary: The following correspondence between Health Canada and potential sponsor(s) regarding the generic submission currently under review for LANREOTIDE: Abbreviated New Drug Submission (ANDS) application forms, draft Product Monograph, Screening Deficiency Notices and Screening Acceptance Letters.
Disposition: Disclosed in part
Number of pages: 25